Suppr超能文献

老年人肠道微生物群失调、肌肉减少症、骨质疏松症和骨肌减少症:一项系统评价方案

Gut microbiota dysbiosis, sarcopenia, osteoporosis and osteosarcopenia in older people: A systematic review protocol.

作者信息

José Neto Nailton, Duarte Brito Mário, Gomes Cristiano Dos Santos, Corrêa Luana Caroline de Assunção Cortez, Guerra Gerlane Coelho Bernardo, Guerra Ricardo Oliveira

机构信息

Graduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.

Physical Therapy Department, University of Pernambuco, Petrolina, Brazil.

出版信息

PLoS One. 2025 Jan 2;20(1):e0313193. doi: 10.1371/journal.pone.0313193. eCollection 2025.

Abstract

INTRODUCTION

Sarcopenia and Osteoporosis are two prevalent conditions in the older population and are defined by low strength, muscle quality/volume and low Bone Mineral Density, respectively. When there is a concomitant presence of both, there is a novel musculoskeletal condition called Osteosarcopenia. These conditions adversely affect quality of life and elevate the risk of fractures, disability, and mortality among older individuals. Dysbiosis of the gut microbiota is the impairment of the mutualistic relationship between microorganisms, metabolic products and the host's immune system. Gut microbiota dysbiosis could be intricately linked to sarcopenia and osteoporosis, shedding light on the complex microbiota-gut-bone-muscle axis. Furthermore, the intestinal microbiota experiences a notable decline in beneficial microorganisms as part of the aging process. The relationship between dysbiosis of the intestinal microbiota in older people and sarcopenia, osteoporosis or osteosarcopenia is still unclear. This review protocol aims to systematically review the literature and compile evidence on the influence of gut microbiota dysbiosis on musculoskeletal function in older people with sarcopenia, osteoporosis or osteosarcopenia.

METHODS/ANALYSIS: This systematic review will analyze observational studies that have investigated the relationship between the effects of gut microbiota dysbiosis and sarcopenia, osteoporosis and osteosarcopenia in older people aged 65 and over. Studies will be retrieved from PubMed/MEDLINE, EMBASE, Scopus, Web of Science and the Cochrane Library. Outcome measures will include body composition for diagnosing osteoporosis and screening for sarcopenia/osteosarcopenia by any criteria. Data synthesis will involve quantitative analysis using summary measures. If sufficient studies, homogeneity and heterogeneity analysis will be performed to conduct Meta-analysis and pooled OR, RR and HR measures will be provided.

摘要

引言

肌肉减少症和骨质疏松症是老年人群中两种常见的病症,分别定义为低强度、肌肉质量/体积低和低骨密度。当两者同时存在时,就会出现一种新的肌肉骨骼病症,称为骨肌减少症。这些病症会对生活质量产生不利影响,并增加老年人骨折、残疾和死亡的风险。肠道微生物群失调是指微生物、代谢产物与宿主免疫系统之间互利关系的受损。肠道微生物群失调可能与肌肉减少症和骨质疏松症有着复杂的联系,揭示了复杂的微生物群-肠道-骨骼-肌肉轴。此外,作为衰老过程的一部分,肠道微生物群中有益微生物的数量会显著下降。老年人肠道微生物群失调与肌肉减少症、骨质疏松症或骨肌减少症之间的关系仍不清楚。本综述方案旨在系统地回顾文献,并收集关于肠道微生物群失调对患有肌肉减少症、骨质疏松症或骨肌减少症的老年人肌肉骨骼功能影响的证据。

方法/分析:本系统综述将分析观察性研究,这些研究调查了65岁及以上老年人肠道微生物群失调的影响与肌肉减少症、骨质疏松症和骨肌减少症之间的关系。研究将从PubMed/MEDLINE、EMBASE、Scopus、科学网和考克兰图书馆中检索。结局指标将包括用于诊断骨质疏松症以及通过任何标准筛查肌肉减少症/骨肌减少症的身体成分。数据合成将涉及使用汇总指标的定量分析。如果有足够的研究,将进行同质性和异质性分析以进行荟萃分析,并提供合并的比值比、相对危险度和风险比指标。

相似文献

1
Gut microbiota dysbiosis, sarcopenia, osteoporosis and osteosarcopenia in older people: A systematic review protocol.
PLoS One. 2025 Jan 2;20(1):e0313193. doi: 10.1371/journal.pone.0313193. eCollection 2025.
2
Effectiveness of exercise for osteosarcopenia in older adults: a systematic review protocol.
BMJ Open. 2021 Jul 2;11(7):e045604. doi: 10.1136/bmjopen-2020-045604.
4
Osteosarcopenia Predicts Falls, Fractures, and Mortality in Chilean Community-Dwelling Older Adults.
J Am Med Dir Assoc. 2021 Apr;22(4):853-858. doi: 10.1016/j.jamda.2020.07.032. Epub 2020 Sep 10.
5
Age-related sarcopenia and altered gut microbiota: A systematic review.
Microb Pathog. 2024 Oct;195:106850. doi: 10.1016/j.micpath.2024.106850. Epub 2024 Aug 13.
6
Osteosarcopenia predicts greater risk of functional disability than sarcopenia: a longitudinal analysis of FraDySMex cohort study.
J Nutr Health Aging. 2024 Nov;28(11):100368. doi: 10.1016/j.jnha.2024.100368. Epub 2024 Sep 21.
9
Effect of osteosarcopenia on longitudinal mortality risk and chronic kidney disease progression in older adults.
Bone. 2024 Feb;179:116975. doi: 10.1016/j.bone.2023.116975. Epub 2023 Nov 20.
10
Gut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia.
Mediators Inflamm. 2018 Jan 30;2018:7026198. doi: 10.1155/2018/7026198. eCollection 2018.

引用本文的文献

1
An Integrated Nutritional and Physical Activity Approach for Osteosarcopenia.
Nutrients. 2025 Aug 31;17(17):2842. doi: 10.3390/nu17172842.

本文引用的文献

1
Gut microbial composition is altered in sarcopenia: A systematic review and meta-analysis of clinical studies.
PLoS One. 2024 Aug 6;19(8):e0308360. doi: 10.1371/journal.pone.0308360. eCollection 2024.
2
Perturbations in gut microbiota composition in osteoporosis: a systematic review and meta-analysis.
J Bone Miner Metab. 2024 Sep;42(5):551-563. doi: 10.1007/s00774-024-01517-3. Epub 2024 Jun 12.
5
Global epidemiological features and impact of osteosarcopenia: A comprehensive meta-analysis and systematic review.
J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):8-20. doi: 10.1002/jcsm.13392. Epub 2023 Dec 12.
6
INFLAMMATORY BOWEL DISEASE AND SARCOPENIA: A FOCUS ON MUSCLE STRENGTH - NARRATIVE REVIEW.
Arq Gastroenterol. 2023 Jul-Sep;60(3):373-382. doi: 10.1590/S0004-2803.230302023-45.
7
Estrogen deficiency induces bone loss through the gut microbiota.
Pharmacol Res. 2023 Oct;196:106930. doi: 10.1016/j.phrs.2023.106930. Epub 2023 Sep 16.
9
Sarcopenia, osteoporosis and frailty.
Metabolism. 2023 Aug;145:155638. doi: 10.1016/j.metabol.2023.155638. Epub 2023 Jun 20.
10
Prevalence and risk factors of osteosarcopenia: a systematic review and meta-analysis.
BMC Geriatr. 2023 Jun 15;23(1):369. doi: 10.1186/s12877-023-04085-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验